Protein and HMB give your muscles the building blocks they need during reduced calorie intake
Furthermore, 2026 will likely bring more clarity on Novo's next-generation drug CagriSema, which combines semaglutide, a GLP-1 agonist, with cagrilintide, an amylin analogue
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
Research dosage protocols vary depending on study objectives, laboratory requirements, and experimental design
Research published in clinical gastroenterology journals found that semaglutide increased gastric retention of solid food by 25.5% at the 2-hour mark, 38.0% at 3 hours, and 30.0% at 4 hours compared to baseline